Apmonia Therapeutics

Reims, France · Founded 2019 · Privately Held (backing)

Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. Apmonia Therapeutics is based in Reims, France and was founded in 2019. Its last reported valuation was $26.8 million in Oct 2025. It has raised $23.9 million.

Last reported valuation

$26.8M

Oct 2026

Priced at

—

Total raised

$23.9M

Last round

—

How much has Apmonia Therapeutics raised?

$23.9Macross 0 recorded rounds

Free account

More of Apmonia Therapeutics with a free account

·The complete investor list: 12 names
·Watch Apmonia Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Apmonia Therapeutics investors

12 investors are on record for Apmonia Therapeutics, including Bpifrance, European Innovation Council, Capital Grand Est and Angels Santé.

For fundraisers

Raising for a company like Apmonia Therapeutics?

12 investors have backed Apmonia Therapeutics.

See all 12 investors →

Frequently asked about Apmonia Therapeutics

How much has Apmonia Therapeutics raised?: Apmonia Therapeutics has raised $23.9M in total across 0 recorded funding rounds.